PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S 3G9, Canada. m.radisic@utoronto.ca.\', \'Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.\', \'Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, M5G 2C4, Canada.\', \'McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, L8S 4L8, Canada.\', \'Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, S7N5E3, Canada.\', \'Sunnybrook Health Sciences Center, Toronto, Ontario, M4N 3M5, Canada.\', \'Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.\', \'Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, M5S 3E5, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1039/d1lc00817j
?:doi
?:hasPublicationType
?:journal
  • Lab on a chip
is ?:pmid of
?:pmid
?:pmid
  • 35142777
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all